Drugs: Licensing

(asked on 13th April 2017) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, who is accountable for monitoring and evaluating the long-term outcomes of the implementation of NICE and NHS England changes to the arrangements for evaluating and funding drugs which will come into effect on 1 April 2017.


This question was answered on 20th April 2017

The National Institute for Health and Care Excellence and NHS England have committed to review the impact of the changes to the arrangements for the assessment and adoption of new treatments three years after their implementation.

Reticulating Splines